ZA952644B - Immunotherapeutic agent and its use - Google Patents

Immunotherapeutic agent and its use

Info

Publication number
ZA952644B
ZA952644B ZA952644A ZA952644A ZA952644B ZA 952644 B ZA952644 B ZA 952644B ZA 952644 A ZA952644 A ZA 952644A ZA 952644 A ZA952644 A ZA 952644A ZA 952644 B ZA952644 B ZA 952644B
Authority
ZA
South Africa
Prior art keywords
immunotherapeutic agent
immunotherapeutic
agent
Prior art date
Application number
ZA952644A
Other languages
English (en)
Inventor
Graham Arthur William Rook
John Lawson Stanford
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of ZA952644B publication Critical patent/ZA952644B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA952644A 1994-03-30 1995-03-30 Immunotherapeutic agent and its use ZA952644B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9406301A GB9406301D0 (en) 1994-03-30 1994-03-30 Immunotherapeutic agent and its use

Publications (1)

Publication Number Publication Date
ZA952644B true ZA952644B (en) 1996-01-11

Family

ID=10752750

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952644A ZA952644B (en) 1994-03-30 1995-03-30 Immunotherapeutic agent and its use

Country Status (22)

Country Link
EP (1) EP0752870B1 (de)
JP (1) JP4135190B2 (de)
KR (1) KR100392582B1 (de)
CN (1) CN1121874C (de)
AP (1) AP9600861A0 (de)
AT (1) ATE218355T1 (de)
AU (1) AU699081B2 (de)
BR (1) BR9507338A (de)
CA (1) CA2186851C (de)
CZ (1) CZ280196A3 (de)
DE (1) DE69526935T2 (de)
DK (1) DK0752870T3 (de)
ES (1) ES2177638T3 (de)
FI (1) FI111223B (de)
GB (1) GB9406301D0 (de)
HU (1) HU220858B1 (de)
NO (1) NO964075L (de)
NZ (1) NZ282863A (de)
PT (1) PT752870E (de)
RU (1) RU2139728C1 (de)
WO (1) WO1995026742A1 (de)
ZA (1) ZA952644B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
CA2273848C (en) * 1996-12-18 2008-02-19 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the th2 activity of the immune system
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
AU2005251397B2 (en) * 2004-06-07 2010-11-11 Qu Biologics Inc. Bacterial compositions for the treatment of cancer
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
BG66067B1 (bg) * 2005-05-18 2011-01-31 Спартак ХАДЖИЕВ Средство с антитуморна активност на база бцж ваксина, метод за неговото получаване и използването му
WO2007112316A2 (en) 2006-03-24 2007-10-04 Morton Donald L Mycobacterial immunotherapy for cancer treatment
KR102157718B1 (ko) 2010-07-26 2020-09-18 큐 바이올로직스 인코포레이티드 면역원성 소염 조성물
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
WO2015164979A1 (en) 2014-05-02 2015-11-05 Qu Biologics Inc. Anti-microbial immunomodulation
MX2017016931A (es) * 2015-06-24 2018-09-26 Immodulon Therapeutics Ltd Inhibidor del punto de regulacion y un mycobaterium de celula entera para uso en la terapia del cancer.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions

Also Published As

Publication number Publication date
CA2186851A1 (en) 1995-10-12
CN1150388A (zh) 1997-05-21
CA2186851C (en) 2008-11-18
DE69526935D1 (de) 2002-07-11
JPH09511737A (ja) 1997-11-25
JP4135190B2 (ja) 2008-08-20
AU2078595A (en) 1995-10-23
FI963866A0 (fi) 1996-09-27
FI111223B (fi) 2003-06-30
AP9600861A0 (en) 1996-10-31
HUT75835A (en) 1997-05-28
WO1995026742A1 (en) 1995-10-12
NO964075L (no) 1996-11-25
CZ280196A3 (en) 1997-02-12
GB9406301D0 (en) 1994-05-25
ATE218355T1 (de) 2002-06-15
EP0752870B1 (de) 2002-06-05
NZ282863A (en) 2001-06-29
MX9604401A (es) 1997-12-31
CN1121874C (zh) 2003-09-24
HU220858B1 (en) 2002-06-29
EP0752870A1 (de) 1997-01-15
DK0752870T3 (da) 2002-07-15
NO964075D0 (no) 1996-09-27
BR9507338A (pt) 1997-09-16
PT752870E (pt) 2002-09-30
RU2139728C1 (ru) 1999-10-20
KR100392582B1 (ko) 2003-10-30
FI963866A (fi) 1996-09-27
KR970702057A (ko) 1997-05-13
DE69526935T2 (de) 2002-09-19
ES2177638T3 (es) 2002-12-16
AU699081B2 (en) 1998-11-19
HU9602661D0 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
IL115891A0 (en) Hemorrhoidial compositions and their use
ZA9711141B (en) Novel ketobenzamides and their use
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
EP0776339A4 (de) Mhc-komplexe und ihre verwendung
GB9406301D0 (en) Immunotherapeutic agent and its use
EP0768038A3 (de) Backfett unf dessen Verwendung
ZA9684B (en) Composition and use
GB9411045D0 (en) Compounds and use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
EP0744125A3 (de) Jodkomplex und dessen Verwendung
EP0754701A4 (de) Neue progesteronverbindung und ihre verwendung
EP0799225A4 (de) Verbindungen und verfahren
GB9423267D0 (en) Compounding elements and use thereof
GB9525048D0 (en) Composition compound and use
GB9412618D0 (en) Cytotoxic agent and its use
GB9413076D0 (en) Composition and use
ZA959512B (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhy-droxyureas
GB9412689D0 (en) Cytotoxic agent and its use
GB9403333D0 (en) Compound and use
GB9420243D0 (en) Complex and its use
GB9525024D0 (en) Composition compound and use
GB9426435D0 (en) Compound and its use
GB9512703D0 (en) Composition and use
GB9411634D0 (en) Use and compounds
GB9417562D0 (en) Compounds and their use